CPT code 83014: H pylori dose, for carbon-13 testing2026 Medicare lab fee · Clinical Laboratory Fee Schedule

Reports administration of medication for Helicobacter pylori testing, separately from the carbon-13 breath or blood assay used to detect infection.

CMS CLFS 2026 Q4Effective Oct 1, 2026Same amount nationwide36.7K Medicare services in 2024

Medicare pays $7.86 for 83014 under the 2026 Clinical Laboratory Fee Schedule: one national amount, the same in every state and setting.

Medicare lab fee · CLFS 2026 Q4

National CLFS amount

$7.86

In effect since Jan 1, 2026. The same amount in every state, payment locality and setting.

Geographic adjustment
None
Office vs facility
Same
Since 2020
Unchanged
CMS updates
Quarterly

Medicare pays the lesser of the lab’s charge and this amount. Patients usually owe no Part B deductible or coinsurance for covered clinical lab tests.

On this page 8 sections
  1. Medicare lab fee
  2. What 83014 covers
  3. How it’s paid
  4. Amount history
  5. Similar tests
  6. Related codes
  7. Billing questions
  8. Sources

What 83014 covers

83014 reports administration of the medication used in an H. pylori test. It is associated with carbon-13 testing: code 83013 identifies breath-test analysis, while 83009 identifies carbon-13 blood testing. The administration service is distinct from specimen analysis; report the applicable test-analysis code for that service as well.

Report 83014 for the administration service; it is not counted by breath specimens or test results. It is commonly reported with 83013 for carbon-13 breath testing and with 83009 for carbon-13 blood testing. Medicare pays 83014 only through the CLFS. The 2026 national CLFS amount is $7.86, unchanged since 2020; the same amount applies in every state and locality, without geographic or office/facility adjustment. It is excluded from the physician fee schedule.

This summary was written with AI assistance from CMS Clinical Laboratory Fee Schedule data. Amounts on this page come directly from CMS files.

How Medicare pays 83014

Clinical lab tests aren’t priced like physician services. They’re paid from their own fee schedule, with its own rules. See the whole lab fee schedule.

One national amount

CMS sets a single Clinical Laboratory Fee Schedule amount for 83014. There’s no geographic (GPCI) adjustment, so it pays the same in every state and payment locality.

No office or facility rate

Lab tests aren’t built from relative value units, so there’s no office and facility split: the place of service doesn’t change the CLFS amount.

Updated every quarter

CMS republishes the CLFS each quarter. New tests, often proprietary laboratory analyses (PLA codes), join during the year; existing amounts are updated each January.

Excluded from the physician fee schedule

The physician fee schedule lists 83014 with status X (excluded by statute), so the test itself is paid only from the CLFS.

83014 on the lab fee schedule since 2020

83014 · CLFS 2026 Q4 (current)

$7.86

Unchanged since Jan 1, 2020

Amount in each year’s latest CLFS release · bars start at $0

27 quarterly CLFS releases on file, first CLFS 2020 Q1. A code missing from a quarter wasn’t on that release.

83014 compared with similar tests

83013H. pylori Breath TestCarbon-13 urease analysis$67.36
83013 reports analysis of the carbon-13 breath test. Use 83014 for the associated drug-administration service, not the analysis.
83009H pylori testC-13 blood analysis$67.36
83009 identifies carbon-13 H. pylori blood testing. Code 83014 reports the associated drug-administration service.
87338H. pylori antigenStool immunoassay$14.38
87338 detects H. pylori antigen in stool; it is a different testing method, not the carbon-13 drug-administration service.

83014 billing questions

Should 83014 be reported with 83013?

Yes, when the drug is administered for carbon-13 H. pylori breath testing. Code 83014 reports administration, and 83013 reports breath-test analysis.

Can 83014 be reported with 83009?

It may be reported with 83009 when the drug is administered for carbon-13 H. pylori blood testing.

Does 83014 report the breath-test result?

No. It reports drug administration; 83013 reports carbon-13 breath-test analysis.

How should units be counted?

Report the drug-administration service, not individual breath specimens or test results.

How does Medicare pay 83014?

Medicare pays it through the CLFS at one national amount across localities and settings. It is excluded from the physician fee schedule.

Where this amount comes from

FeeBase reads lab amounts directly from the CMS Clinical Laboratory Fee Schedule file for the quarter: one row per code, with its payment indicator and national amount. Contractor-priced tests are labeled, never given a made-up amount. Amounts are Medicare payment limits, not a patient’s bill or a commercial rate.

CMS CLFS 2026 Q4 · effective Oct 1, 2026 through the day before Jan 1, 2027

Show the CMS file line behind this amount
CLFS row for 83014PUF_CLFS_CY2026_Q4V1.csv, line 1,275 (CLFS 2026 Q4)

Open CMS sourceHow we source rates

Did this answer your question about what Medicare pays for 83014?

Tell us what you were actually trying to work out. We’ll answer you directly, or build the page that does.

Fee sheets · Coming soon

Put 83014 and the rest of your codes on one sheet

Your codes at your locality, with payer contracts beside Medicare.

Join the waitlist